Barclays PLC Bio Sig Technologies, Inc. Transaction History

Barclays PLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.18 - $3.93 $7,525 - $13,566	-3,452 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$2.71 - $4.35 $8,241 - $13,228	-3,041 Reduced 46.84%	3,452 $10,000
Q2 2021 Aug 13, 2021	SELL	$2.94 - $4.75 $42,212 - $68,200	-14,358 Reduced 68.86%	6,493 $25,000
Q1 2021 May 13, 2021	BUY	$3.99 - $5.53 $38,543 - $53,419	9,660 Added 86.32%	20,851 $90,000
Q4 2020 Feb 11, 2021	SELL	$2.99 - $5.79 $8,880 - $17,196	-2,970 Reduced 20.97%	11,191 $44,000
Q3 2020 Nov 12, 2020	SELL	$4.79 - $9.1 $13,268 - $25,207	-2,770 Reduced 16.36%	14,161 $70,000
Q2 2020 Aug 12, 2020	BUY	$3.61 - $11.84 $41,890 - $137,391	11,604 Added 217.83%	16,931 $122,000
Q1 2020 May 13, 2020	SELL	$2.56 - $6.14 $26,972 - $64,691	-10,536 Reduced 66.42%	5,327 $23,000
Q4 2019 Feb 10, 2020	BUY	$5.78 - $8.11 $46,956 - $65,885	8,124 Added 104.97%	15,863 $94,000
Q3 2019 Nov 14, 2019	SELL	$6.55 - $9.36 $15,458 - $22,089	-2,360 Reduced 23.37%	7,739 $64,000
Q2 2019 Aug 14, 2019	BUY	$5.92 - $9.47 $59,786 - $95,637	10,099 New	10,099 $95,000

88.1K

Ticker BSGM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,814,400
Market Cap $81.6M
Description
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal ...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.